USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
At commercial scale, Bluestem's patent pending technologies will reduce carbon emission by an estimated 75% or more and be cost-competitive with petroleum based chemicals
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
The conference is also expected to pave the way for nations to come out with bold and specific political commitments in the 2024 UN General Assembly High-Level Meeting on AMR
Subscribe To Our Newsletter & Stay Updated